Additionally, CCAT2 genetic polymorphisms were closely related to the susceptibility of lung cancer cells to platinum‐based chemotherapy response; thus, it may be an underlying biomarker for the disease prediction and chemotherapy response.39 This evidence concerns the gene CCAT2 and lung carcinoma.